loadpatents
name:-0.13258910179138
name:-0.03514289855957
name:-0.010699033737183
HINKLIN; Ronald Jay Patent Filings

HINKLIN; Ronald Jay

Patent Applications and Registrations

Patent applications and USPTO patent grants for HINKLIN; Ronald Jay.The latest application filed is for "protein tyrosine phosphatase inhibitors".

Company Profile
9.32.36
  • HINKLIN; Ronald Jay - Longmont CO
  • Hinklin; Ronald Jay - Boulder CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Protein Tyrosine Phosphatase Inhibitors
App 20220251083 - BLAKE; James Francis ;   et al.
2022-08-11
KRAS G12C inhibitors
Grant 11,267,812 - Fischer , et al. March 8, 2
2022-03-08
Bicyclic fused pyridine compounds as inhibitors of TAM kinases
Grant 11,247,990 - Allen , et al. February 15, 2
2022-02-15
Protein Tyrosine Phosphatase Inhibitors
App 20210380582 - BLAKE; James Francis ;   et al.
2021-12-09
Kras G12c Inhibitors
App 20210269432 - FISCHER; John P. ;   et al.
2021-09-02
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
Grant 11,104,676 - Hinklin , et al. August 31, 2
2021-08-31
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
Grant 11,028,093 - Allen , et al. June 8, 2
2021-06-08
Protein Tyrosine Phosphatase Inhibitors
App 20200317665 - BLAKE; James F. ;   et al.
2020-10-08
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20200291039 - Allen; Shelley ;   et al.
2020-09-17
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
Grant 10,730,880 - Allen , et al.
2020-08-04
Quinoline Compounds As Inhibitors Of Tam And Met Kinases
App 20200216416 - Cook; Adam ;   et al.
2020-07-09
KRas G12C inhibitors
Grant 10,633,381 - Blake , et al.
2020-04-28
PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES
App 20200079770 - Hinklin; Ronald Jay ;   et al.
2020-03-12
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20190177328 - Allen; Shelley ;   et al.
2019-06-13
Kras G12c Inhibitors
App 20190062330 - Blake; James F. ;   et al.
2019-02-28
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
Grant 10,189,845 - Allen , et al. Ja
2019-01-29
KRas G12C inhibitors
Grant 10,125,134 - Blake , et al. November 13, 2
2018-11-13
Kras G12c Inhibitors
App 20180072723 - Blake; James F. ;   et al.
2018-03-15
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS
App 20170362240 - Allen; Shelley ;   et al.
2017-12-21
Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives
Grant 9,079,890 - Aicher , et al. July 14, 2
2015-07-14
Intermediates For The Preparation Of Pyridin-2-yl-amino-1,2,4-thiadiazole Derivatives
App 20150057448 - Aicher; Thomas Daniel ;   et al.
2015-02-26
Glucokinase activators
Grant 8,933,077 - Aicher , et al. January 13, 2
2015-01-13
2-aminopyridine analogs as glucokinase activators
Grant 8,883,828 - Aicher , et al. November 11, 2
2014-11-11
Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
Grant 8,853,409 - Aicher , et al. October 7, 2
2014-10-07
Piperidinyl-substituted Lactams As Gpr119 Modulators
App 20140256756 - Aicher; Thomas Daniel ;   et al.
2014-09-11
Piperidinyl-substituted lactams as GPR119 modulators
Grant 8,754,226 - Aicher , et al. June 17, 2
2014-06-17
Piperidinyl-substituted Lactams As Gpr119 Modulators
App 20130184257 - Aicher; Thomas Daniel ;   et al.
2013-07-18
Selective estrogen receptor modulator for the treatment of osteoarthritis
Grant 8,476,300 - Dodge , et al. July 2, 2
2013-07-02
Piperidinyl-substituted Lactams As Gpr119 Modulators
App 20130158009 - Aicher; Thomas Daniel ;   et al.
2013-06-20
2-aminopyridine derivatives as glucokinase activators
Grant 8,431,713 - Aicher , et al. April 30, 2
2013-04-30
2-aminopyridine Analogs As Glucokinase Activators
App 20130065901 - AICHER; Thomas Daniel ;   et al.
2013-03-14
2-aminopyridine analogs as glucokinase activators
Grant 8,362,037 - Aicher , et al. January 29, 2
2013-01-29
2-aminopyridine analogs as glucokinase activators
Grant 8,354,540 - Aicher , et al. January 15, 2
2013-01-15
Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
App 20120277242 - AICHER; Thomas Daniel ;   et al.
2012-11-01
Selective estrogen receptor modulators for the treatment of vasomotor symptoms
Grant 8,217,032 - Dally , et al. July 10, 2
2012-07-10
Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
Grant 8,212,045 - Aicher , et al. July 3, 2
2012-07-03
Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Grant 8,088,776 - Aicher , et al. January 3, 2
2012-01-03
2-aminopyridine Analogs As Glucokinase Activators
App 20110281874 - AICHER; Thomas D. ;   et al.
2011-11-17
Selective Estrogen Receptor Modulators For The Treatment Of Vasomotor Symptoms
App 20110281847 - Dally; Robert Dean ;   et al.
2011-11-17
2-aminopyridine analogs as glucokinase activators
Grant 8,022,223 - Aicher , et al. September 20, 2
2011-09-20
Glucokinase activators
Grant 8,022,222 - Aicher , et al. September 20, 2
2011-09-20
Selective Estrogen Receptor Modulator for the Treatment of Osteoarthritis
App 20110166182 - Dodge; Jeffrey Alan ;   et al.
2011-07-07
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Grant 7,834,194 - Aicher , et al. November 16, 2
2010-11-16
Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
App 20100204240 - Aicher; Thomas Daniel ;   et al.
2010-08-12
Cycloalkyl Lactam Derivatives As Inhibitors Of 11-beta-hydroxysteroid Dehydrogenase 1
App 20100184764 - AICHER; Thomas Daniel ;   et al.
2010-07-22
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Grant 7,713,979 - Aicher , et al. May 11, 2
2010-05-11
2-aminopyridine Analogs As Glucokinase Activators
App 20100105659 - Aicher; Thomas Daniel ;   et al.
2010-04-29
2-aminopyridine Derivatives As Glucokinase Activators
App 20100099713 - Aicher; Thomas Daniel ;   et al.
2010-04-22
Glucokinase Activators
App 20100056530 - Aicher; Thomas D. ;   et al.
2010-03-04
Glucokinase Activators
App 20090247526 - Aicher; Thomas D. ;   et al.
2009-10-01
Biphenyl Amide Lactam Derivatives As Inhibitors Of 11-beta-hydroxysteroid Dehydrogenase 1
App 20090156571 - Aicher; Thomas Daniel ;   et al.
2009-06-18
2-aminopyridine Analogs As Glucokinase Activators
App 20090156603 - Aicher; Thomas D. ;   et al.
2009-06-18
Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms
App 20090023917 - Dally; Robert Dean ;   et al.
2009-01-22
Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
App 20080275043 - Aicher; Thomas Daniel ;   et al.
2008-11-06
Selective Estrogen Receptor Modulators
App 20080227814 - Dodge; Jeffrey Alan ;   et al.
2008-09-18
Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
App 20080214621 - Aicher; Thomas Daniel ;   et al.
2008-09-04
Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
App 20080207691 - Aicher; Thomas Daniel ;   et al.
2008-08-28
Pentacyclic oxepines and derivatives thereof, compositions and methods
Grant 7,271,264 - Hinklin , et al. September 18, 2
2007-09-18
Pentacyclic oxepines and derivatives thereof, compositions and methods
App 20050261277 - Hinklin, Ronald Jay ;   et al.
2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed